Neosplice Therapeutics, Inc.
Biotechnology company · New York, United States
Neosplice Therapeutics, Inc. is a biotechnology company headquartered in New York, United States. It has received 2 NIH small-business research grants, $727,816 in total.
Profile compiled from public records. Is this your company? Request a correction or update
Neosplice Therapeutics at a glance
Typebiotechnology company
HeadquartersNew York, United States
What does Neosplice Therapeutics do?
US government research funding
2 NIH small-business research grants, $727,816 in total. NIH funding came from the National Cancer Institute, National Center for Advancing Translational Sciences.
Frequently asked questions about Neosplice Therapeutics
Where is Neosplice Therapeutics headquartered?
Neosplice Therapeutics, Inc. is headquartered in New York, United States.
What does Neosplice Therapeutics do?
Neosplice Therapeutics, Inc. is a biotechnology company.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences